The Changing Landscape of Treatment for Cystic Fibrosis Related Diabetes

The Changing Landscape of Treatment for Cystic Fibrosis Related Diabetes

Objective: Patients with Cystic Fibrosis related diabetes [CFRD] are treated with insulin and high calorie diets to maintain body mass. The combined CFTR modulator elexacaftor/tezacaftor/ivacaftor [ETI] decreases pulmonary exacerbations and improves nutritional status. We reviewed the effects of ETI...

Full description

Bibliographic Details
Main Authors: Mehdia Amini, Kevin Yu, Jessica Liebich, Vaishaliben Ahir, Emily Wood, Stewart Albert, Sandeep Dhindsa
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Cystic fibrosis
Diabetes
Elexacaftor
Tezacaftor
Ivacaftor
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623724000036

Internet

http://www.sciencedirect.com/science/article/pii/S2214623724000036

Similar Items